- Home
- AVTX vs TOUR Comparison
AVTX vs TOUR Comparison
Compare AVTX & TOUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVTX
- TOUR
- Stock Information
- Founded
- AVTX 2011
- TOUR 2006
- Country
- AVTX United States
- TOUR China
- Employees
- AVTX N/A
- TOUR N/A
- Industry
- AVTX Biotechnology: Pharmaceutical Preparations
- TOUR Transportation Services
- Sector
- AVTX Health Care
- TOUR Consumer Discretionary
- Exchange
- AVTX Nasdaq
- TOUR Nasdaq
- Market Cap
- AVTX 118.6M
- TOUR 98.6M
- IPO Year
- AVTX 2015
- TOUR 2014
- Fundamental
- Price
- AVTX $9.88
- TOUR $0.88
- Analyst Decision
- AVTX Strong Buy
- TOUR
- Analyst Count
- AVTX 8
- TOUR 0
- Target Price
- AVTX $31.00
- TOUR N/A
- AVG Volume (30 Days)
- AVTX 335.9K
- TOUR 227.2K
- Earning Date
- AVTX 08-07-2025
- TOUR 08-15-2025
- Dividend Yield
- AVTX N/A
- TOUR 4.09%
- EPS Growth
- AVTX N/A
- TOUR N/A
- EPS
- AVTX N/A
- TOUR 0.03
- Revenue
- AVTX $441,000.00
- TOUR $75,532,120.00
- Revenue This Year
- AVTX N/A
- TOUR $16.99
- Revenue Next Year
- AVTX N/A
- TOUR $13.23
- P/E Ratio
- AVTX N/A
- TOUR $25.40
- Revenue Growth
- AVTX N/A
- TOUR 7.57
- 52 Week Low
- AVTX $3.39
- TOUR $0.75
- 52 Week High
- AVTX $16.00
- TOUR $1.76
- Technical
- Relative Strength Index (RSI)
- AVTX 76.24
- TOUR 60.66
- Support Level
- AVTX $8.41
- TOUR $0.76
- Resistance Level
- AVTX $9.80
- TOUR $0.85
- Average True Range (ATR)
- AVTX 0.85
- TOUR 0.05
- MACD
- AVTX -0.01
- TOUR 0.01
- Stochastic Oscillator
- AVTX 87.52
- TOUR 97.58
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
About TOUR Tuniu Corporation
Tuniu Corp is an online leisure travel company. The company is engaged in the provision of travel-related services in the People's Republic of China. It offers a large selection of packaged tours, including organized tours and self-guided tours, as well as travel-related services for leisure travelers. The company's organized tours provide pre-arranged itineraries, transportation, accommodations, entertainment, meals, and tour guide services. Its self-guided tours consist of combinations of flights and hotel bookings and other optional add-ons. The company derives almost all of its revenue from PRC.